Skip to main content
. 2021 Jun 30;12:698677. doi: 10.3389/fimmu.2021.698677

Figure 4.

Figure 4

Different binding sites between HLA-G/ILT-2 and HLA-G/ILT-4. ILT-2 residues Tyr38 and Tyr76 bind Phe195 in HLA-G α3 domain, ILT-4 residues Tyr36 and Arg38 bind Phe195–Tyr197 loop in HLA-G α3 domain. (A) ILT-2 binds HLA-G heavy chain associated with β2m (HLA-G1 and HLA-G5). (B) ILT-4 binds both β2m-free (HLA-G2 and HLA-G6) and β2m-associated (HLA-G1 and HLA-G5) HLA-G heavy chain. (C) A panel of novel HLA-G isoforms including isoforms without α1 domain and transmembrane region, or with an extended 5’-region generated by HLA-G mRNA alternative splicing were predicted. However, molecular structure of these novel isoforms and remain to be identified, and interaction with ILTs is unknown yet. Inline graphic and Inline graphic represent ILT-2 and ILT-4 binding site in HLA-G isoforms.